Canada vs Honduras: Access to anti-retroviral drugs, male
Canada
78.0%
in 2022
Honduras
76.0%
in 2024
Canada rank
51st
Honduras rank
54th
Access to anti-retroviral drugs, male over time
- Canada
- Honduras
How they compare
Canada currently reports 78.0% against 76.0% in Honduras, a difference of 2.0%.
Across all 23 years both countries report, Canada has been ahead every year.
Canada ranks 51st and Honduras ranks 54th of 141 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Honduras | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.0% | 10.1% | 21.9% | Canada |
| 2010s | 64.5% | 45.1% | 19.4% | Canada |
| 2020s | 79.0% | 66.7% | 12.3% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Canada or Honduras?
- Canada, at 78.0% against 76.0% in Honduras as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Canada and Honduras?
- 2.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Honduras?
- 23 years are reported by both, from 2000 to 2022.
- How do Canada and Honduras rank globally for access to anti-retroviral drugs, male?
- Canada ranks 51st and Honduras ranks 54th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.